Emergent BioSolutions Inc (EBS)
3.89
+0.59
(+17.88%)
USD |
NYSE |
May 03, 16:00
3.93
+0.04
(+1.03%)
After-Hours: 20:00
Emergent BioSolutions Total Long Term Debt (Quarterly): 860.20M for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 860.20M |
| September 30, 2023 | 861.80M |
| June 30, 2023 | 903.20M |
| March 31, 2023 | 1.398B |
| December 31, 2022 | 1.406B |
| September 30, 2022 | 1.053B |
| June 30, 2022 | 825.20M |
| March 31, 2022 | 833.10M |
| December 31, 2021 | 841.00M |
| September 30, 2021 | 848.90M |
| June 30, 2021 | 854.00M |
| March 31, 2021 | 859.10M |
| December 31, 2020 | 874.80M |
| September 30, 2020 | 879.40M |
| June 30, 2020 | 787.20M |
| March 31, 2020 | 789.20M |
| December 31, 2019 | 811.30M |
| September 30, 2019 | 823.40M |
| June 30, 2019 | 840.50M |
| March 31, 2019 | 742.50M |
| December 31, 2018 | 794.60M |
| September 30, 2018 | 13.50M |
| June 30, 2018 | 13.48M |
| March 31, 2018 | 13.47M |
| December 31, 2017 | 13.50M |
| Date | Value |
|---|---|
| September 30, 2017 | 248.99M |
| June 30, 2017 | 248.69M |
| March 31, 2017 | 248.39M |
| December 31, 2016 | 268.09M |
| September 30, 2016 | 267.79M |
| June 30, 2016 | 247.39M |
| March 31, 2016 | 247.19M |
| December 31, 2015 | 246.89M |
| September 30, 2015 | 253.00M |
| June 30, 2015 | 253.00M |
| March 31, 2015 | 251.00M |
| December 31, 2014 | 251.00M |
| September 30, 2014 | 251.00M |
| June 30, 2014 | 251.00M |
| March 31, 2014 | 251.00M |
| December 31, 2013 | 62.00M |
| September 30, 2013 | 59.42M |
| June 30, 2013 | 60.54M |
| March 31, 2013 | 61.66M |
| December 31, 2012 | 62.77M |
| September 30, 2012 | 63.01M |
| June 30, 2012 | 62.20M |
| March 31, 2012 | 60.87M |
| December 31, 2011 | 59.45M |
| September 30, 2011 | 53.79M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
787.20M
Minimum
Jun 2020
1.406B
Maximum
Dec 2022
913.15M
Average
854.00M
Median
Jun 2021
Total Long Term Debt (Quarterly) Benchmarks
| Avid Bioservices Inc | 141.42M |
| Viking Therapeutics Inc | -- |
| FibroGen Inc | 71.93M |
| Avinger Inc | 14.29M |
| RAPT Therapeutics Inc | -- |